Biohaven Pharma (BHVN) Tops Q1 EPS by 41c
Tweet
Share
E-mail
Get Alerts BHVN Hot Sheet
Join SI Premium – FREE
Biohaven Pharma (NYSE: BHVN) reported Q1 EPS of ($0.98), $0.41 better than the analyst estimate of ($1.39).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biohaven Pharma (BHVN) PT Raised to $23 at RBC Capital
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
